BPIFB4 and COVID-19: In a monocyte-dependent manner, LAV-BPIFB4 was able to induce a distinct T cell response upon SARS-CoV-2 lysate stimulation, described to be both protective (48 hours) and self-limiting (72 hours; Figure 3A and B), that would be relevant in conferring protection from the “cytokine storm” to which several tissues, such as bronchial cells (Supplementary Figure 1B), are exposed in COVID-19.